Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	SKŘIČKOVÁ Jana KEILOVÁ Jana JANÁSKOVÁ Tereza KOLEK Vítězslav CHALUPA Jiří ROUBEC Jaromír TŘASOŇ Tomáš TOMÍŠKOVÁ Marcela KADLEC Bohdan ŠVECOVÁ Jiřina GRYGÁRKOVÁ Ivona KOHOUTEK Milan
Year of publication	2009
Type	Article in Periodical
Magazine / Source	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	Vinorelbine intravenous and oral; carboplatin; first line treatment in advanced non-small lung cancer (NSCLC) patients; preliminary results of a prospective study
Description	Preliminary results are presented of a prospective trial of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in patients with advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study
Related projects:	Environment - carcinogenesis - oncology